Major histocompatibility complex class II (human leukocyte antigen [HLA]-DR) serotypes in Iraqi Arabic patients with Guillain-Barré syndrome (GBS) in comparison with a healthy control group.
| HLA alleles | GBS patients with complications (n=12) | GBS patients without complications (n=18) | P-value |
|---|---|---|---|
| n (%) | |||
| DRB1* | |||
| 03:01 | 6 (50.0) | 8 (44.4) | 1.000 |
| 03:42 | 0 | 2 (11.1) | NA |
| 03:76 | 0 | 2 (11.1) | NA |
| 04:01 | 2 (16.7) | 2 (11.1) | 1.000 |
| 07:01 | 4 (33.3) | 8 (44.4) | 0.708 |
| 11:01 | 2 (16.7) | 4 (33.3) | 1.000 |
| 11:02 | 2 (16.7) | 0 | NA |
| 11:119 | 2 (16.7) | 0 | NA |
| 11:13 | 0 | 2 (11.1) | NA |
| 12:01 | 0 | 4 (33.3) | NA |
| 13:01 | 6 (50.0) | 0 | NA |
| 15:01 | 2 (16.7) | 4 (33.3) | NA |
| DRB3* | |||
| 01:01 | 10 (83.3) | 14 (77.8) | 1.000 |
| DRB4* | |||
| 01:01 | 6 (50.0) | 12 (66.7) | 0.458 |